3 Results for "

hypouricemic effects

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "hypouricemic effects" in MCE Product Catalog:

Cat. No.: HY-146297
CAS No.: 2396612-45-4
Target:  

Xanthine Oxidase

Research Areas:  

Metabolic Disease

Xanthine oxidoreductase-IN-2 (Compound IVa) is a xanthine oxidoreductase (XOR) inhibitor with the IC50 of 7.2 nM. Xanthine oxidoreductase-IN-2 shows hypouricemic effects in mice .
loading...
    loading...
Cat. No.: HY-168740
CAS No.: 2416416-13-0
Target:  

URAT1

Research Areas:  

Metabolic Disease

URAT1 inhibitor 11 (Compound 7) is a URAT1 inhibitor with an IC50 value of 0.18 μM. URAT1 inhibitor 11 exhibits potent hypouricemic effects in hyperuricemic zebrafish induced by Potassium oxonate (HY-17511) and Xanthine sodium salt (HY-W017389) .
loading...
    loading...
Cat. No.: HY-144456
CAS No.: 2276711-87-4
Target:  

Xanthine Oxidase

Research Areas:  

Metabolic Disease

Xanthine oxidase-IN-5 is an effective and orally active xanthine oxidase (XO) inhibitor with IC50 value of 0.70 μM. Xanthine oxidase-IN-5 displays favorable agent-like properties with ligand efficiency (LE) and lipophilic ligand efficiency (LLE) values of 0.33 and 3.41, respectively. Xanthine oxidase-IN-5 shows potent hypouricemic effects in hyperuricemic rat model .
loading...
    loading...